-
Methylnaltrexone (MNTX,
brand name
Relistor), used in form of
methylnaltrexone bromide (INN, USAN, BAN), is a
medication that acts as a
peripherally acting...
- Rela
relacatib (USAN)
Relafen relcovaptan (INN)
Relenza Releuko Relfydess Relistor relomycin (INN)
Relpax remacemide (INN) Reme-T
Remeron remestemcel-L (USAN)...
-
methylnaltrexone (
Relistor®) for opioid-induced
constipation in
advanced illness patients. In 2014, the FDA
approved the
Relistor subcutaneous injection...
- Pharmaceuticals) is
supporting an investigator-initiated
Phase 2
study of
Relistor. The drug is
intended for
patients with
resectable squamous cell carcinoma...
- in the
public domain.
Waknine Y (8 May 2008). "FDA Approvals: Advair,
Relistor, Aplenzin". Medscape.
Archived from the
original on 6 July 2022. Retrieved...
- committee. He also co-invented a drug,
methylnaltrexone (MTNX,
trade name
Relistor), and took it
through phase 2 trials. In May 2008,
methylnaltrexone received...
- pump
inhibitor for
treating dyspepsia,
duodenal ulcers and
Oesophagitis Relistor (methylnaltrexone): a
newly approved drug for
constipation induced by opioids...
